Gourley C - Search Results

1

Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer.

Langdon SP, Herrington CS, Hollis RL, Gourley C. Langdon SP, et al. Among authors: gourley c. Cancers (Basel). 2020 Jun 22;12(6):1647. doi: 10.3390/cancers12061647. Cancers (Basel). 2020. PMID: 32580290 Free PMC article. Review.

2

Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients.

Smyth JF, Gourley C, Walker G, MacKean MJ, Stevenson A, Williams AR, Nafussi AA, Rye T, Rye R, Stewart M, McCurdy J, Mano M, Reed N, McMahon T, Vasey P, Gabra H, Langdon SP. Smyth JF, et al. Among authors: gourley c. Clin Cancer Res. 2007 Jun 15;13(12):3617-22. doi: 10.1158/1078-0432.CCR-06-2878. Clin Cancer Res. 2007. PMID: 17575226 Free article. Clinical Trial.

3

Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.

Gray TA, MacLaine NJ, Michie CO, Bouchalova P, Murray E, Howie J, Hrstka R, Maslon MM, Nenutil R, Vojtesek B, Langdon S, Hayward L, Gourley C, Hupp TR. Gray TA, et al. Among authors: gourley c. J Immunol Methods. 2012 Apr 30;378(1-2):20-32. doi: 10.1016/j.jim.2012.01.013. Epub 2012 Feb 15. J Immunol Methods. 2012. PMID: 22361111

4

Endocrine therapy in epithelial ovarian cancer.

Langdon SP, Gourley C, Gabra H, Stanley B. Langdon SP, et al. Among authors: gourley c. Expert Rev Anticancer Ther. 2017 Feb;17(2):109-117. doi: 10.1080/14737140.2017.1272414. Epub 2016 Dec 24. Expert Rev Anticancer Ther. 2017. PMID: 27967255 Free article. Review.

5

Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.

Hollis RL, Meynert AM, Churchman M, Rye T, Mackean M, Nussey F, Arends MJ, Sims AH, Semple CA, Herrington CS, Gourley C. Hollis RL, et al. Among authors: gourley c. BMC Cancer. 2018 Jan 3;18(1):16. doi: 10.1186/s12885-017-3981-2. BMC Cancer. 2018. PMID: 29298688 Free PMC article.

6

Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment.

Xintaropoulou C, Ward C, Wise A, Queckborner S, Turnbull A, Michie CO, Williams ARW, Rye T, Gourley C, Langdon SP. Xintaropoulou C, et al. Among authors: gourley c. BMC Cancer. 2018 Jun 5;18(1):636. doi: 10.1186/s12885-018-4521-4. BMC Cancer. 2018. PMID: 29866066 Free PMC article.

7

Endocrine treatment of high grade serous ovarian carcinoma; quantification of efficacy and identification of response predictors.

Stanley B, Hollis RL, Nunes H, Towler JD, Yan X, Rye T, Dawson C, Mackean MJ, Nussey F, Churchman M, Herrington CS, Gourley C. Stanley B, et al. Among authors: gourley c. Gynecol Oncol. 2019 Feb;152(2):278-285. doi: 10.1016/j.ygyno.2018.11.030. Epub 2018 Nov 28. Gynecol Oncol. 2019. PMID: 30501904

8

Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse.

Hollis RL, Carmichael J, Meynert AM, Churchman M, Hallas-Potts A, Rye T, MacKean M, Nussey F, Semple CA, Herrington CS, Gourley C. Hollis RL, et al. Among authors: gourley c. Am J Obstet Gynecol. 2019 Sep;221(3):245.e1-245.e15. doi: 10.1016/j.ajog.2019.04.035. Epub 2019 May 2. Am J Obstet Gynecol. 2019. PMID: 31055034 Free PMC article.

9

High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.

Hollis RL, Churchman M, Michie CO, Rye T, Knight L, McCavigan A, Perren T, Williams ARW, McCluggage WG, Kaplan RS, Jayson GC, Oza A, Harkin DP, Herrington CS, Kennedy R, Gourley C. Hollis RL, et al. Among authors: gourley c. Cancer. 2019 Aug 15;125(16):2772-2781. doi: 10.1002/cncr.32079. Epub 2019 Jun 2. Cancer. 2019. PMID: 31154673 Free PMC article.

10

Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma.

Hollis RL, Stanley B, Iida Y, Thomson J, Churchman M, Rye T, Mackean M, Nussey F, Gourley C, Herrington CS. Hollis RL, et al. Among authors: gourley c. Gynecol Oncol. 2019 Nov;155(2):318-323. doi: 10.1016/j.ygyno.2019.09.001. Epub 2019 Sep 5. Gynecol Oncol. 2019. PMID: 31495455 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page